Roche Diagnostics (Roche), a subsidiary of F. Hoffmann-La Roche Ltd, is a diagnostic solution provider that offers pharmaceutical and diagnostic solutions. The company's products include blood glucose monitors, coagulation monitors, point-of-care systems, lancing systems and screening systems. Roche Diagnostics offers instrumentation, kits and support for nucleic acid test donor screening for HIV, hepatitis and west nile virus. The company offers products in the fields of diabetes care and anticoagulation therapy, molecular biology, clinical chemistry, immunology and applied science. It serves the needs of researchers, physicians, patients, hospitals and laboratories. Roche is headquartered in Laval, Quebec, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Roche Diagnostics
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Roche Diagnostics Company Overview
Roche Diagnostics Company Snapshot
Roche Diagnostics Pipeline Products and Ongoing Clinical Trials Overview
Roche Diagnostics – Pipeline Analysis Overview
Roche Diagnostics - Key Facts
Roche Diagnostics - Major Products and Services
Roche Diagnostics Pipeline Products by Development Stage
Roche Diagnostics Pipeline Products Overview
Elecsys EBV EBNA IgG
Elecsys EBV EBNA IgG Product Overview
Elecsys EBV IgM
Elecsys EBV IgM Product Overview
Elecsys EBV VCA IgG
Elecsys EBV VCA IgG Product Overview
LightMix Modular Virus Test Kit - Monkeypox
LightMix Modular Virus Test Kit - Monkeypox Product Overview
LightMix Modular Virus Test Kit - Orthopoxvirus
LightMix Modular Virus Test Kit - Orthopoxvirus Product Overview
LightMix Modular Virus Test Kit - Orthopoxvirus+Monkeypox
LightMix Modular Virus Test Kit - Orthopoxvirus+Monkeypox Product Overview
Roche Elecsys NfL Test
Roche Elecsys NfL Test Product Overview
Roche Diagnostics - Key Competitors
Roche Diagnostics - Key Employees
Roche Diagnostics - Locations And Subsidiaries
Head Office
Recent Developments
Roche Diagnostics, Recent Developments
Nov 16, 2023: Roche launches automated Elecsys hepatitis E immunoassays
Nov 09, 2023: Roche’s MS test scores FDA breakthrough device designation
Aug 17, 2023: Roche Diagnostics Receives 510(k) Clearance for Elecsys Syphilis For Use On Cobas Pro Serology Solution
Aug 17, 2023: Roche Diagnostics Receives 510(k) Clearance for PreciControl Release Syphilis
Aug 17, 2023: Roche Diagnostics Receives 510(k) Clearance for PreciControl Syphilis
Jul 31, 2023: Roche Diagnostics Receives an Additional 510(k) Clearance for the Elecsys proBNP II STAT
Jul 31, 2023: Roche Diagnostics Receives Additional 510(k) Clearance for Elecsys proBNP II
Jun 28, 2023: Roche secures FDA approval for new Alzheimer's disease assays
Jun 26, 2023: Roche Diagnostics Receives 510(k) Clearance for Elecsys Total-Tau CSF Assay